Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF420 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | C21orf2 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | PIDD1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | RIMKLA | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | ZNF3 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | SH3PXD2A | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | RAB9B | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |